InVivo NSA, an animal nutrition and health leader based in France, recently announced that it has reached an agreement to acquire Pancosma, a Switzerland-based worldwide leader of physiological feed additives
InVivo Animal Nutrition & Health ranks among the world leaders in its sector, with revenues of $1.8 billion and a presence in 19 countries. The rapidly-expanding group is eager to quickly consolidate its position in the fast growing sector of specialty additives, the announcement said.
Pancosma was founded in 1947 and has, for more than 65 years, been developing, manufacturing and distributing innovative feed additives worldwide. It is active in a range of seven different product lines such as flavouring and sweetening palatants, bioactives, organic trace minerals, vegetable-based charcoals, acidifiers blends and TakTik’s. The company offers transversal tailor-made solutions for specific needs.
Pancosma owns manufacturing plants in five different countries: France, Switzerland, Canada, Poland and China. Each one is specialised in the manufacturing of one or several product ranges, ensuring a high level of manufacturing process know-how and better risk control.
Financial details were not disclosed at this time. Subject to customary conditions, the transaction is expected to close before the end of the year.
The Invivo Animal Nutrition & Health Group operates five main businesses: complete feeds, premixes, additives, analysis laboratories and animal health. It employs 5,500 people in 19 countries and 65 production sites.
"*" indicates required fields
Notifications
Your Privacy Matters
It's your legal right to choose which information a website may store and have access to. With your permission, we and our third-party partners (19) store and/or access information on a device, such as unique identifiers in cookies and browsing data to collect and process personal data.
We and our partners do the following data processing:
Store and/or access information on a device, Advertising based on limited data and advertising measurement, Personalised content, content measurement, audience research, and services development
If you accept any or all of these, you will have agreed to this website's use of cookies for these purposes. You may also choose to refuse consent, but certain personalized features of the site won't be available to you.